These three high-throughput testing facilities have been set up strategically at ICMR-National Institute of Cancer Prevention and Research, Noida, ICMR-National Institute for Research in Reproductive Health, Mumbai and ICMR-National Institute of Cholera and Enteric Diseases, Kolkata. They will be able to test over 10,000 samples a day.
These labs will also reduce turn-around-time and exposure of lab personnel to infectious clinical materials. The labs are enabled to test diseases other than COVID as well. Post the pandemic, the labs will be able to test for Hepatitis B and C, HIV, Mycobacterium tuberculosis, Cytomegalovirus, Chlamydia, Neisseria, and Dengue.